-

Actylis Achieves Silver EcoVadis Rating, Demonstrating Commitment to Sustainability Excellence

NEW YORK--(BUSINESS WIRE)--Actylis, a leading global manufacturer of critical raw materials and performance ingredients for the life sciences and specialty chemicals markets, is proud to announce its attainment of a Silver rating from EcoVadis, solidifying its position in the 85th percentile among industry peers. This remarkable achievement underscores Actylis' unwavering commitment to sustainable practices and its dedication to fostering a more responsible and eco-conscious future.

What makes this achievement even more remarkable is the fact that we received the certification as a chemical manufacturer, a process known for its more stringent requirements. This is not only a reflection of our resolve to make a positive impact at every stage of our operations, but also underscores our dedication to sustainability..

During a company-wide announcement this week, Gilles Cottier, CEO at Actylis, said "This Silver EcoVadis rating is a momentous achievement that validates our commitment to sustainability. It is a clear signal that Actylis is at the forefront of responsible business practices."

Actylis’ Head of Sustainability, Varun Vijay Rao, added, "This accolade is a tribute to the collective effort and diligence of all our employees who have worked tirelessly to embed sustainable practices into our operations. It's a testimony to our enduring commitment to doing better for our planet and our communities."

This is just a stepping stone on our journey to make the world a better place. We are deeply thankful to all our employees and partners who have contributed to this accomplishment. We look forward to their continued support as we continue to push the boundaries of sustainability.

About Actylis

Actylis is a leading global manufacturer and supplier of differentiated specialty ingredients to life sciences and specialty chemicals end markets. With business operations in ten countries, Actylis manufactures and supplies over 4,500 chemical compounds used principally by the pharmaceutical, biopharmaceutical, nutritional, agricultural and specialty chemical industries. Building on a series of strategic acquisitions, Actylis has integrated their manufacturing, R&D, quality, and sourcing capabilities to create a worldwide supplier of critical raw materials that includes a robust manufacturing footprint. Its global operations include a significant presence on the ground in North America, Europe, India, and China. Actylis is well positioned to innovate new solutions, ensure quality, and customize products to meet customers’ specific needs. Its expanded capabilities and decades of global sourcing expertise are especially valuable now that supply chain management is a critical strategic issue for companies worldwide. For more information, visit https://actylis.com/About-Us/Actylis-Sustainability-Journey.

Contacts

Media
Paul Staunton
Actylis
pstaunton@actylis.com

Actylis


Release Versions

Contacts

Media
Paul Staunton
Actylis
pstaunton@actylis.com

More News From Actylis

Actylis and Novo Nordisk Pharmatech Announce a Strategic Partnership for the Distribution of Benzalkonium Chloride in Targeted European Countries.

NEW YORK--(BUSINESS WIRE)--Actylis and Novo Nordisk Pharmatech A/S have entered into an agreement for the distribution of pharmaceutical grade Benzalkonium Chloride (BKC) to the pharmaceutical and medical device markets in Germany, Spain, Portugal, UK and Ireland. By combining Novo Nordisk Pharmatech’s leading position as a manufacturer of the highest standards of pharmaceutical grade quaternary ammonium compounds (Quats), with Actylis’ expertise and infrastructure in critical raw material dist...

Actylis Launches a New cGMP WFI Generation, Storage, and Distribution System with Additional ISO Class 7 Manufacturing Space as Part of Its Continued Commitment to Supporting Biopharmaceutical Manufacturing

MONTREAL--(BUSINESS WIRE)--Actylis, a leading global manufacturer of critical raw materials and performance ingredients for the life sciences and specialty chemicals markets, today announced the launch of Water for Injection (WFI) and additional ISO Class 7 manufacturing space at its Baie d’Urfé site in Montreal, Canada. Used for the preparation of media, buffers, and other aqueous solutions, Actylis’ WFI meets monographs for pharmacopoeias worldwide, and can be provided in both custom and stan...

Innovassynth and Actylis partner to address Nucleic Acid Supply Chain Vulnerabilities

PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Innovassynth and Actylis announce a strategic partnership in Life Sciences and Specialty Chemicals....
Back to Newsroom